Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
Division of Animal Experimentation, Department of Pulmonary and Critical Care Medicine, Hospital Clinic, Barcelona, Spain.
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01922-18. Print 2019 Feb.
Describing the disposition of antimicrobial agents at the site of infection is crucial to guide optimal dosing for investigational agents. For antibiotics in development for the treatment of nosocomial pneumonia, concentrations in the epithelial lining fluid (ELF) of the lung are frequently determined from a bronchoscopy at a single time point. The influence of profiles constructed from a single ELF concentration point for each subject has never been reported. This study compares the pharmacokinetics of two β-lactams, ceftolozane and piperacillin, among different ELF sampling approaches using simulated human regimens in a swine pneumonia model. Plasma and ELF concentration-time profiles were characterized in two-compartment models by the use of robustly sampled ELF concentrations and by the random selection of one or two ELF concentrations from each swine. A 5,000-subject Monte Carlo simulation was performed for each model to define the ELF penetration, as described by the ratio of the area under the concentration curve (AUC) for ELF to the AUC for free drug in plasma (AUC/AUC) and the probability of target attainment (PTA). Given the intersubject variability of the ELF penetrations observed, differences between the models developed using robust numbers of ELF samples versus one or two ELF samples per swine were minimal for both drugs (maximum dispersion < 20%). Using a threshold exposure target of 60% of the time that the free drug concentration remains above the MIC target, the ceftolozane and piperacillin regimens achieved PTAs of ≥90% at MICs of up to 4 and 1 μg/ml, respectively, among the different ELF sampling strategies. These models suggest that the ELF models constructed with concentrations from sparse ELF sampling time points result in exposure estimates similar to those constructed from robustly sampled ELF profiles.
描述抗菌药物在感染部位的分布对于指导研究药物的最佳剂量至关重要。对于开发用于治疗医院获得性肺炎的抗生素,肺上皮衬液 (ELF) 中的浓度通常通过单次支气管镜检查在单个时间点确定。从未报道过从每个受试者的单个 ELF 浓度点构建的概况的影响。本研究使用猪肺炎模型中的模拟人体方案,比较了两种β-内酰胺类药物头孢洛扎和哌拉西林在不同 ELF 采样方法中的药代动力学。通过使用稳健采样的 ELF 浓度和从每头猪随机选择一个或两个 ELF 浓度,在两室模型中对血浆和 ELF 浓度-时间曲线进行了特征描述。对于每个模型进行了 5000 个主题的 Monte Carlo 模拟,以定义 ELF 穿透率,如 ELF 下面积与游离药物血浆 AUC(AUC/AUC)的比率以及目标实现概率(PTA)来描述。鉴于观察到的 ELF 穿透率的个体间变异性,使用稳健数量的 ELF 样本与每头猪一个或两个 ELF 样本开发的模型之间的差异对于两种药物都很小(最大分散度<20%)。使用游离药物浓度保持高于 MIC 目标的时间的 60%作为暴露目标,头孢洛扎和哌拉西林方案在不同的 ELF 采样策略中,在 MIC 高达 4 和 1μg/ml 时,PTA 均≥90%。这些模型表明,使用稀疏 ELF 采样时间点的浓度构建的 ELF 模型可产生与使用稳健采样的 ELF 谱图构建的暴露估计相似的结果。